Stem cell treatment improves post stroke neurological outcomes: a comparative study in male and female rats.
- Nalamolu K.R. [1] [10] ,
- Chelluboina B. [1] [4] ,
- Fornal C.A. [2] ,
- Challa S.R. [2] ,
- Pinson D.M. [3] ,
- Wang D.Z. [6] [5] ,
- Klopfenstein J.D. [1] [7] [8] and
-
Veeravalli K.K.
[1] [6] [7] [9]

Links
Repository
Description
BACKGROUND AND PURPOSE
The therapeutic potential of different stem cells for ischaemic stroke treatment is intriguing and somewhat controversial. Recent results from our laboratory have demonstrated the potential benefits of human umbilical cord blood-derived mesenchymal stem cells (MSC) in a rodent stroke model. We hypothesised that MSC treatment would effectively promote the recovery of sensory and motor function in both males and females, despite any apparent sex differences in post stroke brain injury.
METHODS
Transient focal cerebral ischaemia was induced in adult Sprague-Dawley rats by occlusion of the middle cerebral artery. Following the procedure, male and female rats of the untreated group were euthanised 1 day after reperfusion and their brains were used to estimate the resulting infarct volume and tissue swelling. Additional groups of stroke-induced male and female rats were treated with MSC or vehicle and were subsequently subjected to a battery of standard neurological/neurobehavioral tests (Modified Neurological Severity Score assessment, adhesive tape removal, beam walk and rotarod). The tests were administered at regular intervals (at days 1, 3, 5, 7 and 14) after reperfusion to determine the time course of neurological and functional recovery after stroke.
RESULTS
The infarct volume and extent of swelling of the ischaemic brain were similar in males and females. Despite similar pathological stroke lesions, the clinical manifestations of stroke were more pronounced in males than females, as indicated by the neurological scores and other tests. MSC treatment significantly improved the recovery of sensory and motor function in both sexes, and it demonstrated efficacy in both moderate stroke (females) and severe stroke (males).
CONCLUSIONS
Despite sex differences in the severity of post stroke outcomes, MSC treatment promoted the recovery of sensory and motor function in male and female rats, suggesting that it may be a promising treatment for stroke.
Subjects
Affiliations
- Cancer Biology and Pharmacology, College of Medicine University of Illinois
- Cancer Biology and Pharmacology, College of Medicine, University of Illinois, Peoria, Illinois, USA.
- Health Sciences Education, College of Medicine, University of Illinois, Peoria, Illinois, USA.
- Neurological Surgery University of Wisconsin-Madison
- Neurology Barrow Neurological Institute
- Neurology, College of Medicine University of Illinois
- Neurosurgery, College of Medicine University of Illinois
- OSF HealthCare Illinois Neurological Institute
- Pediatrics College of Medicine, University of Illinois
- Pharmaceutical and Biomedical Sciences California Health Sciences University
Publisher
Languages
Citations
- Kenmuir CL , Wechsler LR . Update on cell therapy for stroke. Stroke Vasc Neurol 2017;2:59–64.doi:10.1136/svn-2017-000070 http://www.ncbi.nlm.nih.gov/pubmed/28959493
- Liu X , Ye R , Yan T , et al . Cell based therapies for ischemic stroke: from basic science to bedside. Prog Neurobiol 2014;115:92–115.doi:10.1016/j.pneurobio.2013.11.007 http://www.ncbi.nlm.nih.gov/pubmed/24333397
- Boese AC , Le Q-SE , Pham D , et al . Neural stem cell therapy for subacute and chronic ischemic stroke. Stem Cell Res Ther 2018;9:154,018-0913-2. doi:10.1186/s13287-018-0913-2 http://www.ncbi.nlm.nih.gov/pubmed/29895321
- Chen X , Li Y , Wang L , et al . Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology 2002;22:275–9.doi:10.1046/j.1440-1789.2002.00450.x http://www.ncbi.nlm.nih.gov/pubmed/12564767
- Li WY , Choi YJ , Lee PH , et al . Mesenchymal stem cells for ischemic stroke: changes in effects after ex vivo culturing. Cell Transplant 2008;17:1045–59.doi:10.3727/096368908786991551 http://www.ncbi.nlm.nih.gov/pubmed/19177841
- Kim Y-J , Park H-J , Lee G , et al . Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action. Glia 2009;57:13–23.doi:10.1002/glia.20731 http://www.ncbi.nlm.nih.gov/pubmed/18661552
- Liu Z , Li Y , Zhang RL , et al . Bone marrow stromal cells promote skilled motor recovery and enhance contralesional axonal connections after ischemic stroke in adult mice. Stroke 2011;42:740–4.doi:10.1161/STROKEAHA.110.607226 http://www.ncbi.nlm.nih.gov/pubmed/21307396
- Lai RC , Chen TS , Lim SK . Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regen Med 2011;6:481–92.doi:10.2217/rme.11.35 http://www.ncbi.nlm.nih.gov/pubmed/21749206
- Song M , Mohamad O , Gu X , et al . Restoration of intracortical and thalamocortical circuits after transplantation of bone marrow mesenchymal stem cells into the ischemic brain of mice. Cell Transplant 2013;22:2001–15.doi:10.3727/096368912X657909 http://www.ncbi.nlm.nih.gov/pubmed/23069268
- Acosta SA , Tajiri N , Hoover J , et al . Intravenous bone marrow stem cell grafts preferentially migrate to spleen and abrogate chronic inflammation in stroke. Stroke 2015;46:2616–27.doi:10.1161/STROKEAHA.115.009854 http://www.ncbi.nlm.nih.gov/pubmed/26219646
- Marei HE , Hasan A , Rizzi R , et al . Potential of stem cell-based therapy for ischemic stroke. Front Neurol 2018;9:34. doi:10.3389/fneur.2018.00034 http://www.ncbi.nlm.nih.gov/pubmed/29467713
- Chelluboina B , Klopfenstein JD , Pinson DM , et al . Stem cell treatment after cerebral ischemia regulates the gene expression of apoptotic molecules. Neurochem Res 2014;39:1511–21.doi:10.1007/s11064-014-1341-z http://www.ncbi.nlm.nih.gov/pubmed/24879430
- Chelluboina B , Nalamolu KR , Klopfenstein JD . Stem cell treatment after ischemic stroke alters the expression of DNA damage signaling molecules. Journal of Stem Cell Research & Therapeutics 2016;1:281–8.
- Chelluboina B , Nalamolu KR , Mendez GG , et al . Mesenchymal stem cell treatment prevents post-stroke dysregulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases. Cell Physiol Biochem 2017;44:1360–9.doi:10.1159/000485533 http://www.ncbi.nlm.nih.gov/pubmed/29186705
- Zhu Y , Guan Y-ming , Huang H-li , et al . Human umbilical cord blood mesenchymal stem cell transplantation suppresses inflammatory responses and neuronal apoptosis during early stage of focal cerebral ischemia in rabbits. Acta Pharmacol Sin 2014;35:585–91.doi:10.1038/aps.2014.9 http://www.ncbi.nlm.nih.gov/pubmed/24727940
- Nalamolu KR , Venkatesh I , Mohandass A , et al . Exosomes secreted by the cocultures of normal and oxygen-glucose-deprived stem cells improve post-stroke outcome. Neuromolecular Med 2019;21:529–39.doi:10.1007/s12017-019-08540-y http://www.ncbi.nlm.nih.gov/pubmed/31077035
- Chung D-J , Choi C-B , Lee S-H , et al . Intraarterially delivered human umbilical cord blood-derived mesenchymal stem cells in canine cerebral ischemia. J Neurosci Res 2009;87:3554–67.doi:10.1002/jnr.22162 http://www.ncbi.nlm.nih.gov/pubmed/19642203
- Kim ES , Ahn SY , Im GH , et al . Human umbilical cord blood-derived mesenchymal stem cell transplantation attenuates severe brain injury by permanent middle cerebral artery occlusion in newborn rats. Pediatr Res 2012;72:277–84.doi:10.1038/pr.2012.71 http://www.ncbi.nlm.nih.gov/pubmed/22669296
- Savitz SI , Baron J-C , Fisher M , et al . Stroke treatment academic industry roundtable X: brain cytoprotection therapies in the reperfusion era. Stroke 2019;50:1026–31.doi:10.1161/STROKEAHA.118.023927 http://www.ncbi.nlm.nih.gov/pubmed/31166683
- Kim T , Chelluboina B , Chokkalla AK , et al . Age and sex differences in the pathophysiology of acute CNS injury. Neurochem Int 2019;127:22–8.doi:10.1016/j.neuint.2019.01.012 http://www.ncbi.nlm.nih.gov/pubmed/30654116
- Alkayed NJ , Harukuni I , Kimes AS , et al . Gender-linked brain injury in experimental stroke. Stroke 1998;29:159–66. discussion 166 : [] [published Online First: Jan.doi:10.1161/01.STR.29.1.159 http://www.ncbi.nlm.nih.gov/pubmed/9445346
- Vannucci SJ , Willing LB , Goto S , et al . Experimental stroke in the female diabetic, db/db, mouse. J Cereb Blood Flow Metab 2001;21:52–60.doi:10.1097/00004647-200101000-00007 http://www.ncbi.nlm.nih.gov/pubmed/11149668
- Suzuki S , Gerhold LM , Böttner M , et al . Estradiol enhances neurogenesis following ischemic stroke through estrogen receptors alpha and beta. J Comp Neurol 2007;500:1064–75.doi:10.1002/cne.21240 http://www.ncbi.nlm.nih.gov/pubmed/17183542
- Toung TJ , Traystman RJ , Hurn PD . Estrogen-mediated neuroprotection after experimental stroke in male rats. Stroke 1998;29:1666–70.doi:10.1161/01.STR.29.8.1666 http://www.ncbi.nlm.nih.gov/pubmed/9707210
- Toung TK , Hurn PD , Traystman RJ , et al . Estrogen decreases infarct size after temporary focal ischemia in a genetic model of type 1 diabetes mellitus. Stroke 2000;31:2701–6.doi:10.1161/01.STR.31.11.2701 http://www.ncbi.nlm.nih.gov/pubmed/11062297
- Santizo RA , Xu HL , Ye S , et al . Loss of benefit from estrogen replacement therapy in diabetic ovariectomized female rats subjected to transient forebrain ischemia. Brain Res 2002;956:86–95.doi:10.1016/S0006-8993(02)03484-4 http://www.ncbi.nlm.nih.gov/pubmed/12426050
- Carswell HV , Bingham D , Wallace K , et al . Differential effects of 17beta-estradiol upon stroke damage in stroke prone and normotensive rats. J Cereb Blood Flow Metab 2004;24:298–304.doi:10.1097/01.WCB.0000112322.75217.FD http://www.ncbi.nlm.nih.gov/pubmed/15091110
- Gordon KB , Macrae IM , Carswell HVO . Effects of 17beta-oestradiol on cerebral ischaemic damage and lipid peroxidation. Brain Res 2005;1036:155–62.doi:10.1016/j.brainres.2004.12.052 http://www.ncbi.nlm.nih.gov/pubmed/15725413
- Chen J , Sanberg PR , Li Y , et al . Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 2001;32:2682–8.doi:10.1161/hs1101.098367 http://www.ncbi.nlm.nih.gov/pubmed/11692034
- Komotar RJ , Kim GH , Sughrue ME , et al . Neurologic assessment of somatosensory dysfunction following an experimental rodent model of cerebral ischemia. Nat Protoc 2007;2:2345–7.doi:10.1038/nprot.2007.359 http://www.ncbi.nlm.nih.gov/pubmed/17947976
- Puurunen K , Jolkkonen J , Sirviö J , et al . An alpha(2)-adrenergic antagonist, atipamezole, facilitates behavioral recovery after focal cerebral ischemia in rats. Neuropharmacology 2001;40:597–606.doi:10.1016/S0028-3908(00)00182-9 http://www.ncbi.nlm.nih.gov/pubmed/11249969
- Knutsen AP , Wall DA . Kinetics of T-cell development of umbilical cord blood transplantation in severe T-cell immunodeficiency disorders. J Allergy Clin Immunol 1999;103:823–32.doi:10.1016/S0091-6749(99)70426-4 http://www.ncbi.nlm.nih.gov/pubmed/10329816
- Tse W , Laughlin MJ . Umbilical cord blood transplantation: a new alternative option. Hematology Am Soc Hematol Educ Program 2005;2005:377–83.doi:10.1182/asheducation-2005.1.377 http://www.ncbi.nlm.nih.gov/pubmed/16304407
- Lim JY , Jeong CH , Jun JA , et al . Therapeutic effects of human umbilical cord blood-derived mesenchymal stem cells after intrathecal administration by lumbar puncture in a rat model of cerebral ischemia. Stem Cell Res Ther 2011;2:38.doi:10.1186/scrt79 http://www.ncbi.nlm.nih.gov/pubmed/21939558
- Hocking AM , Gibran NS . Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair. Exp Cell Res 2010;316:2213–9.doi:10.1016/j.yexcr.2010.05.009 http://www.ncbi.nlm.nih.gov/pubmed/20471978
- Huang ZG , Xue D , Preston E , et al . Biphasic opening of the blood-brain barrier following transient focal ischemia: effects of hypothermia. Can J Neurol Sci 1999;26:298–304.doi:10.1017/S0317167100000421 http://www.ncbi.nlm.nih.gov/pubmed/10563216
- Barber PA , Hoyte L , Kirk D , et al . Early T1- and T2-weighted MRI signatures of transient and permanent middle cerebral artery occlusion in a murine stroke model studied at 9.4T. Neurosci Lett 2005;388:54–9.doi:10.1016/j.neulet.2005.06.067 http://www.ncbi.nlm.nih.gov/pubmed/16055267
- Borlongan CV , Hadman M , Sanberg CD , et al . Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke 2004;35:2385–9.doi:10.1161/01.STR.0000141680.49960.d7 http://www.ncbi.nlm.nih.gov/pubmed/15345799
- Iskander A , Knight RA , Zhang ZG , et al . Intravenous administration of human umbilical cord blood-derived AC133+ endothelial progenitor cells in rat stroke model reduces infarct volume: magnetic resonance imaging and histological findings. Stem Cells Transl Med 2013;2:703–14.doi:10.5966/sctm.2013-0066 http://www.ncbi.nlm.nih.gov/pubmed/23934909